These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15672001)

  • 1. Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception.
    Cromer BA; Lazebnik R; Rome E; Stager M; Bonny A; Ziegler J; Debanne SM
    Am J Obstet Gynecol; 2005 Jan; 192(1):42-7. PubMed ID: 15672001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hormonal contraception on bone mineral density after 24 months of use.
    Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A
    Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density in adolescent females using depot medroxyprogesterone acetate.
    Lara-Torre E; Edwards CP; Perlman S; Hertweck SP
    J Pediatr Adolesc Gynecol; 2004 Feb; 17(1):17-21. PubMed ID: 15010034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception.
    Scholes D; LaCroix AZ; Ichikawa LE; Barlow WE; Ott SM
    Arch Pediatr Adolesc Med; 2005 Feb; 159(2):139-44. PubMed ID: 15699307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial.
    Ettinger B; Ensrud KE; Wallace R; Johnson KC; Cummings SR; Yankov V; Vittinghoff E; Grady D
    Obstet Gynecol; 2004 Sep; 104(3):443-51. PubMed ID: 15339752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density.
    Johnson CC; Burkman RT; Gold MA; Brown RT; Harel Z; Bruner A; Stager M; Bachrach LK; Hertweck SP; Nelson AL; Nelson DA; Coupey SM; McLeod A; Bone HG
    Contraception; 2008 Apr; 77(4):239-48. PubMed ID: 18342646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections.
    Harel Z; Johnson CC; Gold MA; Cromer B; Peterson E; Burkman R; Stager M; Brown R; Bruner A; Coupey S; Hertweck P; Bone H; Wolter K; Nelson A; Marshall S; Bachrach LK
    Contraception; 2010 Apr; 81(4):281-91. PubMed ID: 20227543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate.
    Cundy T; Ames R; Horne A; Clearwater J; Roberts H; Gamble G; Reid IR
    J Clin Endocrinol Metab; 2003 Jan; 88(1):78-81. PubMed ID: 12519833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inadequate vitamin D status in adolescents with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate injectable contraceptive: a pilot study.
    Harel Z; Wolter K; Gold MA; Cromer B; Bruner A; Stager M; Bachrach L; Hertweck P; Nelson A; Nelson D; Coupey S; Johnson CC; Burkman R; Bone H
    J Pediatr Adolesc Gynecol; 2010 Aug; 23(4):209-14. PubMed ID: 20471875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
    Clark MK; Sowers MR; Nichols S; Levy B
    Fertil Steril; 2004 Dec; 82(6):1580-6. PubMed ID: 15589863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
    Cundy T; Evans M; Roberts H; Wattie D; Ames R; Reid IR
    BMJ; 1991 Jul; 303(6793):13-6. PubMed ID: 1830502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women.
    Scholes D; LaCroix AZ; Ichikawa LE; Barlow WE; Ott SM
    Contraception; 2004 Feb; 69(2):99-104. PubMed ID: 14759613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects.
    Greenwald MW; Gluck OS; Lang E; Rakov V
    Menopause; 2005; 12(6):741-8. PubMed ID: 16278618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls.
    Cromer BA; Stager M; Bonny A; Lazebnik R; Rome E; Ziegler J; Debanne SM
    J Adolesc Health; 2004 Dec; 35(6):434-41. PubMed ID: 15581522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone biochemical markers in adolescent girls using either depot medroxyprogesterone acetate or an oral contraceptive.
    Rome E; Ziegler J; Secic M; Bonny A; Stager M; Lazebnik R; Cromer BA
    J Pediatr Adolesc Gynecol; 2004 Dec; 17(6):373-7. PubMed ID: 15603978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
    Kaunitz AM; Darney PD; Ross D; Wolter KD; Speroff L
    Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of progestins on bone density and bone metabolism in postmenopausal women: a randomized controlled trial.
    Liu JH; Muse KN
    Am J Obstet Gynecol; 2005 Apr; 192(4):1316-23; discussion 1323-4. PubMed ID: 15846228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of depot medroxyprogesterone acetate on bone mineral density in adolescent women.
    Zhang MH; Zhang W; Zhang AD; Yang Y; Gai L
    Chin Med J (Engl); 2013 Nov; 126(21):4043-7. PubMed ID: 24229671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral density in women using depot medroxyprogesterone acetate for contraception.
    Scholes D; Lacroix AZ; Ott SM; Ichikawa LE; Barlow WE
    Obstet Gynecol; 1999 Feb; 93(2):233-8. PubMed ID: 9932562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis.
    Lovell DJ; Glass D; Ranz J; Kramer S; Huang B; Sierra RI; Henderson CJ; Passo M; Graham B; Bowyer S; Higgins G; Rennebohm R; Schikler KN; Giannini E
    Arthritis Rheum; 2006 Jul; 54(7):2235-42. PubMed ID: 16802360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.